Prestige BioPharma Limited (950210.KS)

KRW 15050.0

(-4.57%)

Total Assets Summary of Prestige BioPharma Limited

  • Prestige BioPharma Limited's latest annual total assets in 2023 was 711.72 Billion KRW , down -4.03% from previous year.
  • Prestige BioPharma Limited's latest quarterly total assets in 2023 Q3 was 710.29 Billion KRW , up 1.26% from previous quarter.
  • Prestige BioPharma Limited reported annual total assets of 741.6 Billion KRW in 2022, up 48.38% from previous year.
  • Prestige BioPharma Limited reported annual total assets of 499.81 Billion KRW in 2021, down -17.27% from previous year.
  • Prestige BioPharma Limited reported quarterly total assets of 739.82 Billion KRW for 2023 Q1, down -0.24% from previous quarter.
  • Prestige BioPharma Limited reported quarterly total assets of 710.29 Billion KRW for 2023 Q3, up 1.26% from previous quarter.

Annual Total Assets Chart of Prestige BioPharma Limited (2023 - 2017)

Historical Annual Total Assets of Prestige BioPharma Limited (2023 - 2017)

Year Total Assets Total Assets Growth
2023 711.72 Billion KRW -4.03%
2022 741.6 Billion KRW 48.38%
2021 499.81 Billion KRW -17.27%
2020 604.16 Billion KRW 277.37%
2019 160.09 Billion KRW 55.55%
2018 102.92 Billion KRW 149.51%
2017 41.24 Billion KRW 0.0%

Peer Total Assets Comparison of Prestige BioPharma Limited

Name Total Assets Total Assets Difference
ORIENT BIO Inc. 96.98 Billion KRW -633.825%
Green Cross Holdings Corporation 3737.7 Billion KRW 80.958%
Green Cross Holdings Corporation 2643.31 Billion KRW 73.075%
Pharmicell Co., Ltd. 99.19 Billion KRW -617.523%
Green Cross Corporation 2643.31 Billion KRW 73.075%
GeneOne Life Science, Inc. 151 Billion KRW -371.314%
Celltrion, Inc. 19917.53 Billion KRW 96.427%
Samsung Biologics Co.,Ltd. 16046.19 Billion KRW 95.565%
SK bioscience Co.,Ltd. 1852.43 Billion KRW 61.579%
SK Biopharmaceuticals Co., Ltd. 723.17 Billion KRW 1.583%